APT(SH:688617)2025-04-22 13:30Financial Performance - The company's operating revenue for Q1 2025 was CNY 564,276,710.67, representing a year-on-year increase of 23.93% compared to CNY 455,327,284.53 in the same period last year[4] - The net profit attributable to shareholders for Q1 2025 was CNY 183,151,687.90, reflecting a growth of 30.69% from CNY 140,143,827.76 in the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 180,530,401.14, up 32.23% from CNY 136,530,234.33 year-on-year[4] - The basic earnings per share for Q1 2025 were CNY 1.89, an increase of 30.34% compared to CNY 1.45 in the previous year[4] - The diluted earnings per share rose by 30.56% to CNY 1.88 from CNY 1.44 year-on-year[4] - Total operating revenue for Q1 2025 reached CNY 564.28 million, a 24% increase from CNY 455.33 million in Q1 2024[16] - Net profit for Q1 2025 was CNY 180.14 million, representing a 31% increase compared to CNY 137.86 million in Q1 2024[17] Cash Flow - The net cash flow from operating activities increased by 45.45%, reaching CNY 166,662,587.49 compared to CNY 114,587,998.06 in the same period last year[4] - In Q1 2025, the cash inflow from operating activities was $661.67 million, a 28.2% increase from $516.00 million in Q1 2024[19] - The net cash flow from operating activities for Q1 2025 was $166.66 million, up 45.5% from $114.59 million in Q1 2024[19] - The cash inflow from operating activities included $634.32 million from sales, up from $506.83 million in the previous year[19] - The total cash outflow from operating activities in Q1 2025 was $495.00 million, compared to $401.42 million in Q1 2024[19] - The company experienced a net increase in cash and cash equivalents of $116.59 million in Q1 2025, contrasting with a decrease of $622.21 million in Q1 2024[20] - The company reported a cash inflow from tax refunds of $5.67 million in Q1 2025, up from $3.78 million in Q1 2024[19] Assets and Liabilities - The total assets at the end of the reporting period were CNY 3,144,592,769.23, a 5.50% increase from CNY 2,980,697,768.82 at the end of the previous year[5] - The company's total liabilities decreased to CNY 408.14 million as of March 31, 2025, from CNY 425.85 million as of December 31, 2024[14] - The total equity attributable to shareholders increased by 7.34% to CNY 2,700,953,801.47 from CNY 2,516,339,545.43 at the end of the previous year[5] - The company's total liabilities were not specified, but accounts payable increased to RMB 53,939,696.98 from RMB 46,315,037.80, indicating a rise of approximately 16.5%[12] - The company's current assets totaled RMB 1,750,830,787.65, up from RMB 1,616,687,606.56, indicating an increase of about 8.3%[12] - The cash and cash equivalents amounted to RMB 1,197,674,280.85, compared to RMB 1,081,087,911.03 in the previous period, representing a growth of approximately 10.8%[11] Research and Development - Research and development expenses totaled CNY 73,969,533.27, which is a 12.73% increase from CNY 65,615,307.81 in the same period last year[4] - The proportion of R&D expenses to operating revenue decreased to 13.11% from 14.41% year-on-year, a reduction of 1.30 percentage points[4] - Research and development expenses for Q1 2025 were CNY 73.97 million, an increase from CNY 65.62 million in Q1 2024[16] Strategic Direction - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided content[10] - The company has not disclosed any significant mergers or acquisitions during the reporting period, maintaining its current strategic direction[10]